+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report by Product, Application, Primary User and Region with Growth Forecasts, 2025-2033- Product Image
Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report by Product, Application, Primary User and Region with Growth Forecasts, 2025-2033- Product Image
New

Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report by Product, Application, Primary User and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 150 Pages
  • November 2025
  • Region: Global
  • Grand View Research
  • ID: 5950101
REQUEST CUSTOMIZATION
Description Jump to:
The global osteoarthritis therapeutics market size was estimated at USD 5.02 billion in 2024 and is projected to reach USD 10.89 billion by 2033, growing at a CAGR of 9.0% from 2025 to 2033. The global osteoarthritis therapeutics market size was estimated at USD 5.02 billion in 2024 and is projected to reach USD 10.89 billion by 2033, growing at a CAGR of 9.0% from 2025 to 2033.

According to the Global Burden of Disease (GBD) Study 2020, approximately 595 million people worldwide were living with osteoarthritis, representing 7.6% of the global population. This number continues to rise, primarily due to demographic shifts and lifestyle factors such as aging and obesity. The GBD report, published in November 2024, noted a sharp increase in OA cases, with approximately 466.3 million new cases recorded in 2021 alone. The condition most commonly affects weight-bearing joints, particularly the knee, making it a growing concern for healthcare systems worldwide. The rise in OA prevalence is particularly pronounced among older populations, with data from the Centers for Disease Control and Prevention (CDC) published in February 2024 indicating that arthritis rates increase substantially with age. In adults aged 75 and older, the prevalence of arthritis is as high as 53.9%, underscoring the strong correlation between aging and OA.

The growing geriatric population is a major driver of market growth, with the World Health Organization (WHO) projecting that by 2050, 16% of the global population is expected to be aged 65 or older. As the elderly population expands, particularly in regions such as Japan and Europe where the aging demographic is more pronounced, the demand for age-specific OA treatments is rising. According to the WHO’s July 2023 report, 73% of individuals living with osteoarthritis are aged 55 or older, highlighting the increasing prevalence of OA in older age groups. This demographic shift has prompted the healthcare industry to focus on therapies that address the unique needs of elderly patients, many of whom also have multiple comorbidities. As of October 2024, healthcare systems are focusing more on geriatric care, emphasizing the development of treatments that improve mobility and overall quality of life for elderly OA patients. Moreover, the growth of the elderly population is catalyzing investments in clinical research to develop innovative therapies, such as biologics and regenerative treatments, aimed at slowing disease progression and enhancing joint function.

Another significant factor driving the osteoarthritis therapeutics market is the rising incidence of sports injuries and accident-related joint damage. As participation in sports and physical activities continues to increase, so does the risk of injuries that lead to joint damage and accelerate the onset of OA. In addition to the direct impact on treatment modalities, these injuries contribute to a growing awareness of the need for joint health management. The International Labour Organization (ILO), in its 2024 report, estimated that 395 million workers worldwide sustain non-fatal work injuries annually, many of which result in long-term joint damage and subsequent OA. Furthermore, the World Health Organization (WHO) reported in 2024 that injuries account for around 4.4 million deaths annually, with a significant portion of these fatalities linked to road accidents. This growing awareness has led to increased interest in preventative measures, such as nutritional supplements, physical therapy, and the development of novel OA treatments aimed at maintaining joint health and improving recovery outcomes. As a result, the osteoarthritis therapeutics market is experiencing an uptick in the development of therapies designed to address both the prevention and treatment of OA, further contributing to market growth.

Global Osteoarthritis Therapeutics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global osteoarthritis therapeutics market report based on product, application, primary user, and region:

Product Outlook (Revenue, USD Million, 2021-2033)

  • Viscosupplements
  • Platelet-Rich Plasma (PRP) Therapy
  • Bone Graft Substitutes
  • BMAC (Bone Marrow Aspirate Concentrate) Therapy
  • Adipose Tissue Therapy
  • Autologous Chondrocyte Implantation (ACI), Including MACI
  • Stem Cell (other)
  • Other (Cartilage Resurfacing Products)

Application Outlook (Revenue, USD Million, 2021-2033)

  • Knee Osteoarthritis
  • Hip Osteoarthritis
  • Shoulder Osteoarthritis
  • Spine Osteoarthritis
  • Ankle & Foot Osteoarthritis
  • Other

Primary User Outlook (Revenue, USD Million, 2021-2033)

  • Orthopedic Surgeons
  • Rheumatologists
  • Sports Medicine Specialists
  • Regenerative Medicine Specialists
  • Other

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Application
1.2.3. Primary User
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Osteoarthritis Therapeutics Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Patent Expiry Analysis
3.3.5. Pricing Analysis
Chapter 4. Osteoarthritis Therapeutics Market: Product Business Analysis
4.1. Product Market Share, 2024 & 2033
4.2. Product Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million)
4.4. Viscosupplements
4.4.1. Viscosupplements Market, 2021-2033 (USD Million)
4.5. Platelet-Rich Plasma (PRP) Therapy
4.5.1. Platelet-Rich Plasma (PRP) Therapy Market, 2021-2033 (USD Million)
4.6. Bone Graft Substitutes
4.6.1. Bone Graft Substitutes Market, 2021-2033 (USD Million)
4.7. BMAC (Bone Marrow Aspirate Concentrate) Therapy
4.7.1. BMAC (Bone Marrow Aspirate Concentrate) Therapy Market, 2021-2033 (USD Million)
4.8. Adipose Tissue Therapy
4.8.1. Adipose Tissue Therapy Market, 2021-2033 (USD Million)
4.9. Autologous Chondrocyte Implantation (ACI), Including MACI
4.9.1. Autologous Chondrocyte Implantation (ACI), Including MACI Market, 2021-2033 (USD Million)
4.10. Stem Cell (other)
4.10.1. Stem Cell (other) Market, 2021-2033 (USD Million)
4.11. Others
4.11.1. Others Market, 2021-2033 (USD Million)
Chapter 5. Osteoarthritis Therapeutics Market: Application Business Analysis
5.1. Application Market Share, 2024 & 2033
5.2. Application Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by application, 2021 to 2033 (USD Million)
5.4. Knee Osteoarthritis
5.4.1. Knee Osteoarthritis Market, 2021-2033 (USD Million)
5.5. Hip Osteoarthritis
5.5.1. Hip Osteoarthritis Market, 2021-2033 (USD Million)
5.6. Shoulder Osteoarthritis
5.6.1. Shoulder Osteoarthritis Market, 2021-2033 (USD Million)
5.7. Spine Osteoarthritis
5.7.1. Spine Osteoarthritis Market, 2021-2033 (USD Million)
5.8. Ankle & Foot Osteoarthritis
5.8.1. Ankle & Foot Osteoarthritis Market, 2021-2033 (USD Million)
5.9. Others
5.9.1. Others Market, 2021-2033 (USD Million)
Chapter 6. Osteoarthritis Therapeutics Market: Primary User Business Analysis
6.1. Primary User Market Share, 2024 & 2033
6.2. Primary User Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by primary user, 2021 to 2033 (USD Million)
6.4. Orthopedic Surgeons
6.4.1. Orthopedic Surgeons Market, 2021-2033 (USD Million)
6.5. Rheumatologists
6.5.1. Rheumatologists Market, 2021-2033 (USD Million)
6.6. Sports Medicine Specialists
6.6.1. Sports Medicine Specialists Market, 2021-2033 (USD Million)
6.7. Regenerative Medicine Specialists
6.7.1. Regenerative Medicine Specialists Market, 2021-2033 (USD Million)
6.8. Others
6.8.1. Others Market, 2021-2033 (USD Million)
Chapter 7. Osteoarthritis Therapeutics Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
7.4.1. North America Osteoarthritis Therapeutics Market Estimates and Forecasts, By Country, 2021-2033 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Application Disease Prevalence
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Framework
7.4.2.5. U.S. Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Application Disease Prevalence
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Framework
7.4.3.5. U.S. Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Application Disease Prevalence
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Framework
7.4.4.5. Mexico Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5. Europe
7.5.1. Europe Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Application Disease Prevalence
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Framework
7.5.2.5. Uk Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Application Disease Prevalence
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Framework
7.5.3.5. Germany Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Application Disease Prevalence
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement Framework
7.5.4.5. France Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Application Disease Prevalence
7.5.5.3. Regulatory Framework
7.5.5.4. Reimbursement Framework
7.5.5.5. Italy Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Application Disease Prevalence
7.5.6.3. Regulatory Framework
7.5.6.4. Reimbursement Framework
7.5.6.5. Spain Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Application Disease Prevalence
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement Framework
7.5.7.5. Denmark Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Application Disease Prevalence
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement Framework
7.5.8.5. Sweden Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Application Disease Prevalence
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement Framework
7.5.9.5. Norway Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6. Asia-Pacific
7.6.1. Asia-Pacific Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Application Disease Prevalence
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Framework
7.6.2.5. Japan Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Application Disease Prevalence
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Framework
7.6.3.5. China Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Application Disease Prevalence
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Framework
7.6.4.5. India Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Application Disease Prevalence
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Framework
7.6.5.5. Australia Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Application Disease Prevalence
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement Framework
7.6.6.5. South Korea Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Application Disease Prevalence
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement Framework
7.6.7.5. Thailand Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7. Latin America
7.7.1. Latin America Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Application Disease Prevalence
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement Framework
7.7.2.5. Japan Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Application Disease Prevalence
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement Framework
7.7.3.5. China Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Application Disease Prevalence
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement Framework
7.8.2.5. South Africa Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Application Disease Prevalence
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement Framework
7.8.3.5. Saudi Arabia Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Application Disease Prevalence
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement Framework
7.8.4.5. UAE Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Application Disease Prevalence
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement Framework
7.8.5.5. Kuwait Osteoarthritis Therapeutics Market Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Stryker
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Zimmer Biomet Holdings, Inc.
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Medtronic
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Anika Therapeutics, Inc.
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Bioventus
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Vericel Corporation
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Smith & Nephew
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Fidia Farmaceutici S.p.A.
8.5.8.1. Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Seikagaku Corporation
8.5.9.1. Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Sanofi
8.5.10.1. Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global osteoarthritis therapeutics market, by region, 2021-2033 (USD Million)
Table 4 Global osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 5 Global osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 6 Global osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 7 North America osteoarthritis therapeutics market, by country, 2021-2033 (USD Million)
Table 8 North America osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 9 North America osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 10 North America osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 11 U.S. osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 12 U.S. osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 13 U.S. osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 14 Canada osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 15 Canada osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 16 Canada osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 17 Mexico osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 18 Mexico osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 19 Mexico osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 20 Europe osteoarthritis therapeutics market, by country, 2021-2033 (USD Million)
Table 21 Europe osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 22 Europe osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 23 Europe osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 24 UK osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 25 UK osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 26 UK osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 27 Germany osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 28 Germany osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 29 Germany osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 30 France osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 31 France osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 32 France osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 33 Italy osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 34 Italy osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 35 Italy osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 36 Spain osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 37 Spain osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 38 Spain osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 39 Norway osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 40 Norway osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 41 Norway osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 42 Denmark osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 43 Denmark osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 44 Denmark osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 45 Sweden osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 46 Sweden osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 47 Sweden osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 48 Asia-Pacific osteoarthritis therapeutics market, by country, 2021-2033 (USD Million)
Table 49 Asia-Pacific osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 50 Asia-Pacific osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 51 Asia-Pacific osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 52 Japan osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 53 Japan osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 54 Japan osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 55 China osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 56 China osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 57 China osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 58 India osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 59 India osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 60 India osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 61 Australia osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 62 Australia osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 63 Australia osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 64 South Korea osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 65 South Korea osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 66 South Korea osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 67 Thailand osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 68 Thailand osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 69 Thailand osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 70 Latin America osteoarthritis therapeutics market, by country, 2021-2033 (USD Million)
Table 71 Latin America osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 72 Latin America osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 73 Latin America osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 74 Brazil osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 75 Brazil osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 76 Brazil osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 77 Argentina osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 78 Argentina osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 79 Argentina osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 80 Middle East & Africa Osteoarthritis therapeutics market, by country, 2021-2033 (USD Million)
Table 81 Middle East & Africa osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 82 Middle East & Africa osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 83 Middle East & Africa osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 84 South Africa osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 85 South Africa osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 86 South Africa osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 87 Saudi Arabia osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 88 Saudi Arabia osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 89 Saudi Arabia osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 90 UAE osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 91 UAE osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 92 UAE osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
Table 93 Kuwait osteoarthritis therapeutics market, by product, 2021-2033 (USD Million)
Table 94 Kuwait osteoarthritis therapeutics market, by application, 2021-2033 (USD Million)
Table 95 Kuwait osteoarthritis therapeutics market, by primary user, 2021-2033 (USD Million)
List of Figures
Figure 1 Osteoarthritis therapeutics market segmentation
Figure 2 Market research process
Figure 3 Data triangulation techniques
Figure 4 Primary research pattern
Figure 5 Market research approaches
Figure 6 Value-chain-based sizing & forecasting
Figure 7 Market formulation & validation
Figure 8 Market snapshot
Figure 9 Therapeutic approach outlook (USD Million)
Figure 10 Competitive landscape
Figure 11 Osteoarthritis therapeutics market dynamics
Figure 12 Osteoarthritis therapeutics market: Porter’s five forces analysis
Figure 13 Osteoarthritis therapeutics market: PESTLE analysis
Figure 14 Product market, 2021-2033 (USD Million)
Figure 15 Viscosupplements market, 2021-2033 (USD Million)
Figure 16 Platelet-Rich Plasma (PRP) Therapy market, 2021-2033 (USD Million)
Figure 17 Bone Graft Substitutes market, 2021-2033 (USD Million)
Figure 18 BMAC (Bone Marrow Aspirate Concentrate) Therapy market, 2021-2033 (USD Million)
Figure 19 Adipose Tissue Therapy market, 2021-2033 (USD Million)
Figure 20 Autologous Chondrocyte Implantation (ACI), Including MACI market, 2021-2033 (USD Million)
Figure 21 Stem Cell (other) Substitutes market, 2021-2033 (USD Million)
Figure 22 Others market, 2021-2033 (USD Million)
Figure 23 Application market, 2021-2033 (USD Million)
Figure 24 Knee Osteoarthritis market, 2021-2033 (USD Million)
Figure 25 Hip Osteoarthritis market, 2021-2033 (USD Million)
Figure 26 Shoulder Osteoarthritis market, 2021-2033 (USD Million)
Figure 27 Spine Osteoarthritis market, 2021-2033 (USD Million)
Figure 28 Ankle & Foot Osteoarthritis market, 2021-2033 (USD Million)
Figure 29 Others market, 2021-2033 (USD Million)
Figure 30 Primary User market, 2021-2033 (USD Million)
Figure 31 Orthopedic Surgeons market, 2021-2033 (USD Million)
Figure 32 Rheumatologists market, 2021-2033 (USD Million)
Figure 33 Sports Medicine Specialists market, 2021-2033 (USD Million)
Figure 34 Regenerative Medicine Specialists market, 2021-2033 (USD Million)
Figure 35 Others market, 2021-2033 (USD Million)
Figure 36 Osteoarthritis therapeutics market revenue, by region
Figure 37 Regional marketplace: Key takeaways
Figure 38 North America osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 39 U.S. country dynamics
Figure 40 U.S. osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 41 Canada country dynamics
Figure 42 Canada osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 43 Mexico country dynamics
Figure 44 Mexico osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 45 Europe osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 46 UK country dynamics
Figure 47 UK osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 48 Germany country dynamics
Figure 49 Germany osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 50 France country dynamics
Figure 51 France osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 52 Italy country dynamics
Figure 53 Italy osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 54 Spain country dynamics
Figure 55 Spain osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 56 Norway country dynamics
Figure 57 Norway osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 58 Sweden country dynamics
Figure 59 Sweden osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 60 Denmark country dynamics
Figure 61 Denmark osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 62 Asia-Pacific osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 63 Japan country dynamics
Figure 64 Japan osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 65 China country dynamics
Figure 66 China osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 67 India country dynamics
Figure 68 India osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 69 Australia country dynamics
Figure 70 Australia osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 71 South Korea country dynamics
Figure 72 South Korea osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 73 Thailand country dynamics
Figure 74 Thailand osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 75 Latin America osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 76 Brazil country dynamics
Figure 77 Brazil osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 78 Argentina country dynamics
Figure 79 Argentina osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 80 MEA osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 81 South Africa country dynamics
Figure 82 South Africa osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 83 Saudi Arabia country dynamics
Figure 84 Saudi Arabia osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 85 UAE country dynamics
Figure 86 UAE osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 87 Kuwait country dynamics
Figure 88 Kuwait osteoarthritis therapeutics market, 2021-2033 (USD Million)
Figure 89 Company categorization
Figure 90 Company market position analysis
Figure 91 Strategic framework

Companies Mentioned

The key companies profiled in this Osteoarthritis Therapeutics market report include:
  • Stryker
  • Zimmer Biomet Holdings, Inc.
  • Medtronic
  • Anika Therapeutics, Inc.
  • Bioventus
  • Vericel Corporation
  • Smith & Nephew
  • Fidia Farmaceutici S.p.A.
  • SEIKAGAKU CORPORATION
  • Sanofi

Table Information

Report AttributeDetails
No. of Pages150
PublishedNovember 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 5.02 Billion
Forecasted Market Value ( USD ) by 2033 $ 10.89 Billion
Compound Annual Growth Rate9.0%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Companion Animal Osteoarthritis Market Size, Share & Trends Analysis Report By Product (Biologics, Viscosupplements, Pharmaceuticals), By Animal (Canine, Feline, Equine), By Route Of Administration, By End Use, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Companion Animal Osteoarthritis Market Size, Share & Trends Analysis Report By Product (Biologics, Viscosupplements, Pharmaceuticals), By Animal (Canine, Feline, Equine), By Route Of Administration, By End Use, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
Osteoarthritis Therapeutics Market Report by Anatomy Type, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033 - Product Image

Osteoarthritis Therapeutics Market Report by Anatomy Type, Drug Type, Route of Administration, Distribution Channel, and Region 2025-2033

  • Report
  • 141 Pages
  • Global
From
Osteoarthritis Therapeutics - Global Strategic Business Report - Product Image

Osteoarthritis Therapeutics - Global Strategic Business Report

  • Report
  • 266 Pages
  • Global
From
Knee Osteoarthritis Drug Pipeline Analysis Report 2025 - Product Image

Knee Osteoarthritis Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Osteoarthritis Drug Pipeline Analysis Report 2025 - Product Image

Osteoarthritis Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • 200 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.